Se proyecta que el mercado global de ensayos de ATP alcance los USD 455,39 millones para 2029 desde USD 225,92 millones en 2020, con una CAGR del 8,1% entre 2022 y 2029.
El crecimiento del mercado se debe principalmente a la transición de las pruebas basadas en cultivos a las pruebas rápidas, la creciente demanda de ensayos basados en células en la investigación y la creciente necesidad de ensayos de ATP en las empresas farmacéuticas. Sin embargo, una limitación a la hora de distinguir entre ATP extracelular e intracelular plantea restricciones a la expansión del mercado.
Los avances tecnológicos han mejorado significativamente la precisión de la cadena de suministro de alimentos . Para garantizar el suministro de productos de la más alta calidad con riesgos mínimos para la salud, varios gobiernos y corporaciones han implementado regulaciones para definir niveles aceptables de contaminantes, residuos y aditivos en los alimentos. Mandatos como los establecidos en la Ley de Modernización de la Inocuidad Alimentaria (FSMA) exigen que las instalaciones de procesamiento de alimentos instituyan protocolos integrales de inocuidad alimentaria y recopilen datos cuantitativos para determinar la eficacia de sus prácticas de limpieza y saneamiento. Este enfoque proactivo mitiga los riesgos de enfermedades transmitidas por los alimentos, cierres de instalaciones y retiradas de productos del mercado, al tiempo que fomenta la eficiencia operativa y reduce los costos.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD) |
| Segmentación | Por producto, por aplicación, por usuario final, por región. |
| Por producto |
|
| Por aplicación |
|
| Por el usuario final |
|
| Por región |
|
According to the World Health Organization (WHO), in 2022, consumption of unsafe food contaminated with harmful bacteria, viruses, parasites, or chemical substances led to the occurrence of over 200 diseases, spanning from gastrointestinal disorders to cancer. An estimated 600 million individuals (nearly 1 in 10 people worldwide) experience illness after consuming tainted food, resulting in approximately 420,000 fatalities annually and a loss of 33 million healthy life years (DALYs).
ATP serves as a universal mediator of metabolism and signaling across both unicellular and multicellular organisms. The intricate interplay between ATP dynamics and cellular physiology extends from intracellular to extracellular levels. Consequently, elucidating and comprehending ATP dynamics yields invaluable mechanistic insights into diverse biological processes, ranging from neurotransmission to immune cell chemotaxis. Consequently, there exists a pressing need for methodologies capable of examining both the temporal and spatial aspects of ATP dynamics across various scales, from subcellular to organismal levels, in live specimens.
The ATP assays market size had crossed USD 225,92 Billion in 2020 and will observe a CAGR of more than 8.1% up to 2029 driven by the rising increasing food safety concerns.
The upcoming trend in ATP assays market is a technological enhancement in ATP assay probes is an opportunity for market growth.
The global ATP assays market registered a CAGR of 8.1% from 2022 to 2029. The product segment was the highest revenue contributor to the market.
Key players profiled in the report include Thermo Fisher Scientific, Inc., Promega Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Abcam plc, Lonza Group, NEOGEN Corporation, 3M, Danaher Corporation, PromoCell GmbH, Geno Technology, Inc., Abnova Corporation, AAT Bioquest, BioThema AB, Elabscience Biotechnology Inc.
Contamination testing segment dominate the application of ATP assays market.
North America is the largest regional market with 43% of share The rising incidence and prevalence of chronic and infectious diseases, rising demand for cell-based assays in research.
The ATP assays market is divided into consumables & accessories, reagent, microplates, other consumables & accessories, instruments, luminometers, spectrophotometers based on product. Consumables & accessories segment dominate the market. The large share of the consumables and accessories segment can be attributed to the widespread use of ATP assays in research institutes to measure cell viability, an increase in drug discovery due to an increase in chronic diseases that necessitate tumour testing and cell proliferation (in cancer), and pharmaceutical and biotechnology companies' repeated purchases of consumables.
The market is divided into contamination testing, disease testing, drug discovery and development based on application. Contamination testing segment dominate the market. The rising regulatory stringency of pharmaceutical and food & beverage companies for non-contaminated production, an increase in drug discovery post COVID-19, and the need for cleaning and disinfection of environmental surfaces in hospitals are all contributing to the contamination testing segment's large share.
The market is divided into pharmaceutical & biotechnology companies, food and beverage industry, hospitals and diagnostic laboratories, academic and research institutions based on end user. Pharmaceutical & biotechnology segment dominate the market. The presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines that require the use of ATP assays in contamination testing, commercial expansion of various pharmaceutical companies, increasing demand for cell and gene therapies for chronic diseases, and significant R&D in pharmaceutical and biotechnology can all be attributed to the pharmaceutical and biotechnology segment's large share.
[caption id="attachment_9060" align="alignnone" width="680"]
The major players operating in the global ATP assays industry include Thermo Fisher Scientific, Inc., Promega Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Abcam plc, Lonza Group, NEOGEN Corporation, 3M, Danaher Corporation, PromoCell GmbH, Geno Technology, Inc., Abnova Corporation, AAT Bioquest, BioThema AB, Elabscience Biotechnology Inc., MBL International Corporation, Biotium, and Creative Bioarray. The presence of established industry players and is characterized by mergers and acquisitions, joint ventures, capacity expansions, substantial distribution, and branding decisions to improve market share and regional presence. Also, they are involved in continuous R&D activities to develop new products as well as are focused on expanding the product portfolio. This is expected to intensify competition and pose a potential threat to the new players entering the market.
Geographically, the ATP assays market is segmented into North America, South America, Europe, APAC and MEA.
North America is expected to hold the largest share of the global ATP assays market. The rising incidence and prevalence of chronic and infectious diseases, rising demand for cell-based assays in research, increasing focus on cell-based therapeutics, favourable government support for research, and the presence of high-quality infrastructure for clinical and laboratory research in the region are all factors contributing to North America's large share.
[caption id="attachment_9063" align="alignleft" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.